Industry News
Tumor location in colorectal cancer may influence survival
Feb 26, 2015
The two halves of the human colon have different embryonic origins and gene expression patterns, and these differences may also play a role in cancer biology, according to a study published in the... Read More
Gene regulatory path revealed as target for therapy of aggressive pediatric brain cancer
Feb 26, 2015
Laboratory studies suggest anticancer drug already in clinical trials in children may interrupt this gene pathwayWorking with cells taken from children with a very rare but ferocious form of... Read More
'Patchwork' ovarian cancer more deadly
Feb 26, 2015
The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published in PLOS Medicine*. Read More
Tumor location in colorectal cancer may influence survival
Feb 26, 2015
The two halves of the human colon have different embryonic origins and gene expression patterns, and these differences may also play a role in cancer biology, according to a study published in the... Read More
Androgen receptor abnormality may not be associated with primary resistance to taxane chemotherapy
Feb 26, 2015
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant... Read More
MD Anderson studies skin cancer patients resistant to leading therapy
Feb 26, 2015
Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein's power to spur cancer cell growth. Read More
What are the health benefits of black beans?
Feb 26, 2015
Find out about the health benefits of black beans including maintaining healthy bones, lowering blood pressure, managing diabetes, preventing cancer and warding off heart disease. Read More
Adjuvant sorafenib and sunitinib do not improve outcomes in locally advanced kidney cancer
Feb 26, 2015
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. Read More
Men who have had testicular cancer are more likely to develop prostate cancer
Feb 26, 2015
Although overall risk of developing aggressive disease is lowA case-control study of close to 180,000 men suggests that the incidence of prostate cancer is higher among men with a history of... Read More
Sunitinib, sorafenib of no benefit in ECOG-ACRIN renal cell trial
Feb 26, 2015
Research results highlighted at the press conference of a major medical meeting report no benefit from the use of either Sutent® (sunitinib) or Nexavar® (sorafenib) among patients with... Read More
Previous Page Next Page